NOVEL PROPOFOL COMPOSITION COMPRISING A PHARMACEUTICALLY ACCEPTABLE SALT OF FORMALDEHYDE SULFOXYLATE
摘要
<p>Sterile pharmaceutical compositions for parenteral administration containing 2,6-diisopropylphenol (propofol) are described for use as anesthetics. The compositions comprise an oil-in-water emulsion of propofol additionally comprising an amount of a pharmaceutically acceptable salt of formaldehyde sulfoxylate sufficient to prevent significant growth of microorganisms for at least 24 hours after adventitious contamination.</p>
